Beth Israel Lahey Health account plan
Comprehensive patient care network
At a glance
Beth Israel Lahey Health is a Massachusetts non-profit health system with $9.7 billion of FY2025 operating revenue and 39,000 employees.
Beth Israel Lahey Health (BILH) is a non-profit health system formed in 2019 from the CareGroup, Lahey and Seacoast systems, and calls itself the second largest health care system in New England, spanning Cape Cod to Southern New Hampshire. It runs an academic medical center (Beth Israel Deaconess Medical Center), teaching hospitals including Lahey and Mount Auburn, the orthopedic New England Baptist Hospital, community hospitals, a behavioral health hospital and physician organisations, and serves more than 2.1 million patients with 39,000 employees and 5,300 physicians. In the fiscal year ended September 30, 2025, total operating revenues were $9,679,967k and income from operations was $93,304k, its first operating gain in four years, after a loss of $(248,951)k in FY2024. Medicare is the largest payer. Kevin Tabb is President and CEO until Peter Shorett takes over in January 2027.
Business units
Patient care: hospitals and physician practices
Patient service revenue $7,564,972k in FY2025 (about 78% of operating revenues, computed)BIDMC in Boston, Lahey Hospital in Burlington, Mount Auburn, New England Baptist and community hospitals such as Northeast, Winchester, Plymouth, Milton, Needham, Anna Jaques and Exeter, plus Harvard Medical Faculty Physicians. In HFY 2025 Lahey Hospital, BIDMC, Northeast and Winchester carried the operating surplus, while Anna Jaques, Milton, New England Baptist and most employed physician groups lost money.
Research and teaching
Research revenue $333,116k in FY2025 (about 3% of operating revenues, computed)Federally funded research concentrated at BIDMC and Joslin Diabetes Center, with $234,164,264 of research and development federal award expenditure in FY2025, mostly from the Department of Health and Human Services.
Pharmacy, contracts, philanthropy and ancillary services
Other revenue $1,781,879k in FY2025 (about 18% of operating revenues, computed)Pharmacy sales, other health-care service contracts, contributions, cafeteria and parking income. It grew from $1,486,102k in FY2024.
Behavioral health and community services
Northeast Behavioral Health provides outpatient, residential, substance abuse and trauma services in northeast Massachusetts, and the system works with six licensed and affiliated community health centers.
Strategic priorities
- Blueprint 2030: care in the community
- Shift care from BIDMC and Lahey to community settings: 64 percent of care is delivered there today, against about half in 2019, with 70 percent targeted by 2030. Outpatient visits rose 11 percent in the last fiscal year.
- Primary care as the front door
- New primary care providers grew 30 percent over four fiscal years, and 60 primary care clinicians joined last year, 20 of them from Mass General Brigham.
- Cancer partnership with Dana-Farber
- A 10-story, 300-bed inpatient cancer hospital on the former Joslin site, connected to BIDMC and scheduled to open in 2031; final state approval came on May 19, 2025.
- Operating as one system
- Supplies, equipment and services are managed as one system, some services were consolidated, and about 600 people were laid off in late 2024.
- Single IT platform
- The Epic electronic medical record roll-out across BILH entities, started in FY2024, was substantially completed by September 30, 2025, with Workday funded by the same bonds.
Latest results
In the fiscal year ended September 30, 2025, total operating revenues rose to $9,679,967k from $8,907,184k and patient service revenue grew 7 percent to $7.6 billion. Income from operations swung to $93,304k from a loss of $(248,951)k, and investment gains lifted the excess of revenues over expenses to $376,173k. Cash flow from operations was $443,988k. In the state's HFY 2025 comparison, BILH's operating margin was 0.9% and total margin 3.8%, against a system median total margin of 4.7%.
Investments and deals
- Series N and O bonds
- In August 2025 BILH issued $893,100k of tax-exempt Series N bonds, funding its share of the Dana-Farber Cancer Facility and other capital projects, and $130,580k of taxable Series O bonds.
- Epic and Workday systems
- Funded in part by the 2023 Series M bonds ($400,000k); the Epic roll-out was substantially complete by September 30, 2025.
- Capital spending
- Purchases of property and equipment were $322,002k in FY2025, with construction in progress of $199,037k.
- New community sites
- An urgent care centre in Haverhill, a large clinic in Middleborough and a Quincy clinic due in 2027.
Challenges and risks
- Public payer dependence
- Medicare reimbursement fell short of cost by $490,750k and Medicaid and other low-income programmes by $308,735k in FY2025; federal Medicaid changes and the One Big Beautiful Bill Act add strain.
- Loss-making hospitals and physician groups
- Anna Jaques, Milton and New England Baptist ran operating losses in HFY 2025, and Lahey Clinic posted the largest physician-organisation loss in the state, $103.1M.
- End of the state price cap
- BILH is leaving a seven-year state price cap imposed as a merger condition, but CEO Kevin Tabb says persuading insurers to pay more is harder.
- Research funding and compliance
- The audit names possible cuts to clinical research funding as a risk and reported one significant deficiency on NIH grant cost allowability at BIDMC and Joslin.
- Ageing plant and leadership transition
- Average age of plant is 17 years, and a new CEO takes over in January 2027 while the cancer hospital project proceeds.
What leadership says
“It's a short-sighted view to say we can't afford to invest in primary care. I take the opposite view. We can't afford not to.”
“Things will get more difficult, not less, in health care in general.”
“I've built my entire career off of really working collaboratively with physician leaders, bringing their voices to the table, and leveraging their expertise.”
Where a supplier can help
- Community and outpatient expansion
- Tied to the Blueprint 2030 priority and new community sites: clinic fit-out, imaging and urgent care equipment, scheduling and patient access tools.
- Revenue cycle and payer contracting
- Tied to the public payer and price cap challenges: revenue cycle, coding and payer analytics that support negotiations with insurers.
- Physician group performance
- Tied to the loss-making physician organisations: practice management, staffing and productivity tools for employed physician groups.
- Systemwide procurement and Epic optimisation
- Tied to the one-system priority and the completed Epic roll-out: group purchasing, supply chain and Epic-integrated applications.
- Cancer hospital construction
- Tied to the Dana-Farber partnership: construction, medical equipment and IT for the 300-bed cancer hospital opening in 2031.
Tamtam's reading of the priorities and challenges above, not the company's own words.
Selling to companies like Beth Israel Lahey Health?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companiesKey documents
Read in full by Tamtam; each summary links to the document itself.
- Beth Israel Lahey Health, Inc. and Affiliates - Consolidated Financial Statements and Single Audit Reports, Year Ended September 30, 2025
- Beth Israel Lahey Health (BILH) is a Massachusetts non-profit (501(c)(3)) health system formed on March 1, 2019 from the CareGroup, Lahey and Seacoast systems; it added Joslin Diabetes Center (November 1, 2021) and Exeter Health Resources (July 1, 2023). It calls itself the second largest health care system in New England, spanning Cape Cod to Southern New Hampshire.
- FY2025 (year ended September 30, 2025): total operating revenues $9,679,967k (FY2024: $8,907,184k); income from operations $93,304k, against a loss of $(248,951)k in FY2024; excess of revenues over expenses $376,173k.
- Revenue mix: patient service revenue $7,564,972k, research revenue $333,116k, other revenue (pharmacy sales, contributions, parking, contracts) $1,781,879k. Medicare is the largest payer at $3,318,832k of patient service revenue, followed by commercial/managed care $1,811,167k and Blue Cross $1,502,815k.
- Cost base: salaries and benefits $5,474,242k and supplies and other expenses $3,710,703k; by function, patient care $7,491,612k, research $427,546k, general and administrative $1,667,505k.
- Balance sheet at September 30, 2025: total assets $10,353,051k, long-term debt net of current portion $2,796,228k, total net assets $4,793,724k; cash and cash equivalents $662,834k.
- Capital programme: Epic electronic medical record roll-out across BILH entities, started in FY2024 and substantially completed by September 30, 2025; purchases of property and equipment $322,002k in FY2025.
- August 2025 financing: $893,100k tax-exempt Series N bonds (funding BILH's share of the Dana-Farber Cancer Facility collaboration, other capital projects and partial defeasance) and $130,580k taxable Series O bonds; commercial paper capacity raised to $300,000.
- Dana-Farber Cancer Institute will own and operate a 300-bed cancer hospital on BIDMC-owned land in the Longwood Medical Area, in clinical collaboration with BILH, BIDMC and HMFP; final state approval came on May 19, 2025.
- Stated sector risks: dependence on Medicare and Medicaid, government regulation and budget constraints including reduced clinical research funding, malpractice claims, and cybersecurity. Medicare reimbursement fell short of cost by $490,750k and Medicaid and other low-income programmes by $308,735k.
- Federal awards expenditure totalled $261,014,266 (research and development $234,164,264). KPMG issued an unmodified opinion and reported one significant deficiency (2025-001) on NIH grant cost allowability at BIDMC and Joslin.
- CHIA - Massachusetts Hospital and Health System Annual Financial Performance Report, HFY 2025 (BILH system, hospitals and physician organisations)
- CHIA's statewide report on Massachusetts hospital and health system finances for hospital fiscal year (HFY) 2025, published September 2026, lists BILH's figures next to every other Massachusetts system.
- BILH system, FYE 9/30: operating margin 0.9%, non-operating margin 2.8%, total margin 3.8%, excess of revenue over expenses $376.2M, current ratio 3.0, debt service coverage 4.7, long-term debt to total capitalisation 43.1%, total net assets $4,793.7M.
- Beth Israel Deaconess Medical Center (academic medical center): operating margin 3.8%, total margin 7.0%, surplus $243.5M, net assets $1,848.9M.
- Lahey Hospital and Medical Center (teaching): operating margin 10.5%, total margin 12.7%, surplus $178.7M; Northeast Hospital had the highest operating margin among hospitals in multi-acute systems, 14.0%, and a $121.2M surplus.
- Loss-making BILH hospitals: Anna Jaques (operating -11.9%, deficit $16.0M), BID-Milton (-9.9%, $10.4M deficit) and New England Baptist (-9.2%, $11.2M deficit).
- BILH's physician organisations all lose money except Harvard Medical Faculty Physicians ($53.7M surplus); Lahey Clinic posted the largest physician-organisation loss in the state, $103.1M.
- Statewide context: the system median total margin was 4.7% and operating margin 0.2%; acute hospital operating revenues rose $5.1 billion (11.3 percent).
- Boston Globe: How Beth Israel Lahey Health turned a profit under Kevin Tabb
- Boston Globe feature (January 24, 2026) on BILH's turnaround under CEO Dr. Kevin Tabb, with his own comments and those of former executives and outside experts.
- Results cited: a $93 million operating gain on $9.7 billion of operating revenue in the year ending September, after losses as high as $249 million in fiscal 2024; patient revenue grew 7 percent to $7.6 billion.
- Scale: 42,000 employees and 14 hospital campuses; 1.7 million patients a year.
- Strategy: Tabb's guiding principle is that 70 percent of care should take place in community hospitals and settings rather than at BIDMC in Boston or Lahey Hospital in Burlington; today 64 percent does.
- Inpatient stays fell year on year while outpatient visits rose by 11 percent; new sites include an urgent care centre in Haverhill, a clinic in Middleborough and a Quincy clinic due in 2027.
- Primary care: 30 percent growth in new primary care providers over four fiscal years and 60 clinicians added last year, 20 of them from Mass General Brigham. Tabb: "We can't afford not to."
- Integration: BILH laid off approximately 600 people in late 2024; supplies, equipment and services are being managed as one system.
- Risks Tabb names: federal changes to Medicaid, more uninsured patients, and harder insurer negotiations as the state's seven-year price cap ends. "Things will get more difficult, not less, in health care in general."
- Boston Globe: Beth Israel Lahey names Peter Shorett as its next CEO
- Boston Globe (October 8, 2026): BILH names Peter Shorett, 46, senior executive vice president and chief operating officer, as CEO from January, succeeding Dr. Kevin Tabb, who has led the organisation and its predecessor for 15 years.
- Shorett was an architect of the 2019 merger, then a senior partner at the consultancy Chartis, and was instrumental in persuading Dana-Farber to leave Mass General Brigham for a partnership with BILH.
- Scale per a spokesperson: more than 2.1 million patients across Eastern Massachusetts and southern New Hampshire, 39,000 employees and 5,300 physicians.
- Strategic plan Blueprint 2030: community-based care rose from about half in 2019 to 64 percent today, with 70 percent targeted by 2030.
- Shorett will oversee the integration of cancer care with Dana-Farber, including a 10-story, 300-bed inpatient cancer hospital on the former Joslin site, connected to BIDMC and scheduled to open in 2031.
- Headwinds named: financial strain from the One Big Beautiful Bill Act.
- Leadership style in his words: working "collaboratively with physician leaders", without a medical degree.
Questions about Beth Israel Lahey Health
What is Beth Israel Lahey Health?
A Massachusetts non-profit health system formed in 2019 that runs Beth Israel Deaconess Medical Center, Lahey, Mount Auburn, New England Baptist, community hospitals and physician organisations across Eastern Massachusetts and southern New Hampshire.
What is Beth Israel Lahey Health's revenue?
Total operating revenues were $9,679,967k in the fiscal year ended September 30, 2025, with income from operations of $93,304k.
How many employees does Beth Israel Lahey Health have?
39,000 employees and 5,300 physicians, per a spokesperson in October 2026.
Who leads Beth Israel Lahey Health?
Dr. Kevin Tabb is President and CEO; Peter Shorett, Senior EVP and COO, becomes CEO in January 2027.
What is Beth Israel Lahey Health's strategy?
Blueprint 2030 moves care to community settings, with 70 percent targeted by 2030, invests in primary care, runs the hospitals as one system, and builds a cancer hospital with Dana-Farber.
Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)